Haya Al Bitar

Haya Al Bitar

Auto-generated profile, based on publicly available information

Haya Al Bitar

Dalhousie University 5 Faculty of Medicine Halifax

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2026 in Academic Medicine
Verified
Journal Article
Closed access
HBHaya Al Bitar
Haya Al Bitar
LCLuke Y C Chen
Luke Y C Chen

18 September 2026 in Journal of Human Immunity
Verified
Journal Article
Open access
DCDerrick H.Y. Chong
Derrick H.Y. Chong
CSCaroline Spaner
Caroline Spaner
IEIbrahim Elsharawi
Ibrahim Elsharawi
MTMark Trinder
Mark Trinder
HBHaya Al Bitar
Haya Al Bitar
LCLuke Y.C. Chen
Luke Y.C. Chen
Adult-onset Still’s disease (AOSD) is a diagnostic challenge, as its features overlap with many inflammatory syndromes and no single finding is diagnostic. Skin biopsies showing dyskeratotic keratinocytes (DKs) in the superficial epidermis, including the horny layer, are thought to be highly specific for AOSD but are not included in current diagnostic or classification criteria. We conducted a retrospective clinicopathological study of 16 adults with confirmed AOSD and skin biopsies from a Canadian rare diseases program, and developed a differential diagnosis for superficial DKs using expert consensus and literature review. Clinical morphology varied, but histopathology was similar: 12 of 16 patients had DKs or necrotic keratinocytes in the upper epidermis. Superficial DKs have been reported in conditions distinct from AOSD, but not in its major mimics. Skin biopsy is low-cost, minimally invasive, and widely available and should be performed early in suspected AOSD; superficial DKs should be added to future diagnostic and classification criteria.

22 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
HBHaya Al Bitar
Haya Al Bitar
KVKarla N. Valenzuela-Valderas
Karla N. Valenzuela-Valderas
ELEdwin Leong
Edwin Leong
JBJasmine Barra
Jasmine Barra
JRJohn Rohde
John Rohde
IHIan D. Haidl
Ian D. Haidl
Shigella species initiate intracellular infection that targets the intestinal epithelial lining and cause the gastrointestinal illness, shigellosis. Following entry into gut microfold (M) cells, Shigella transcytoses to the submucosal tissue, where it interacts with leukocytes and re-infects epithelial cells from the basolateral surface. Although mast cells are immune sentinel cells abundant in the intestinal submucosa, little is known about their response to Shigella exposure. The interaction of Shigella with mouse and human cultured mast cells was therefore characterized. Shigella successfully invaded mouse and human mast cells in a type III secretion system-dependent manner. In contrast to most other cell types, mast cells not only survived infection but also progressively reduced their intracellular bacterial burden over time. Mouse and human mast cells produced a cell entry-independent pro-inflammatory response to Shigella, including interleukin-6 (IL-6) and IL-1β induction. In addition, murine mast cells initiated a type I interferon response to intracellular Shigella, mediated by the stimulator of interferon genes (STING) pathway and inhibited by the Shigella effector IpaJ. This identifies STING signaling as a key mechanism for mast cell activation during Shigella infection. The ability of mast cells to control intracellular Shigella infection while also producing pro-inflammatory cytokines, chemokines, and interferons underlines the unique role of these cells as early responders to infection at mucosal surfaces. Further understanding these novel processes may provide new opportunities to enhance effective host responses to Shigella infection.